Cargando…

Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?

BACKGROUND: We are reporting a series of interesting cases, which presented to us with psoriasiform lesions distributed over the acral regions of the body. The cases are unusual because they were resistant to conventional treatment modalities like topical corticosteroids, tacrolimus and oral methotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Arghyaprasun, Aggarwal, Ishad, De, Abhishek, Samanta, Ayan, Chatterjee, Gobinda, Bala, Sanchaita, Biswas, Projna, Chowdhary, Nidhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372904/
https://www.ncbi.nlm.nih.gov/pubmed/25814700
http://dx.doi.org/10.4103/0019-5154.152507
_version_ 1782363251693060096
author Ghosh, Arghyaprasun
Aggarwal, Ishad
De, Abhishek
Samanta, Ayan
Chatterjee, Gobinda
Bala, Sanchaita
Biswas, Projna
Chowdhary, Nidhi
author_facet Ghosh, Arghyaprasun
Aggarwal, Ishad
De, Abhishek
Samanta, Ayan
Chatterjee, Gobinda
Bala, Sanchaita
Biswas, Projna
Chowdhary, Nidhi
author_sort Ghosh, Arghyaprasun
collection PubMed
description BACKGROUND: We are reporting a series of interesting cases, which presented to us with psoriasiform lesions distributed over the acral regions of the body. The cases are unusual because they were resistant to conventional treatment modalities like topical corticosteroids, tacrolimus and oral methotrexate but showed significant improvement on oral zinc therapy. MATERIALS AND METHODS: Ten patients with characteristic clinical features of distinctive hyperkeratotic plaque in the acral areas, who were resistant to treatment by different modalities including potent topical steroids and oral methotrexate, were included for detailed investigations. A proper history was taken and relevant laboratory investigations were done which included blood count, urine, liver function, renal function, hepatitis-C virus serology and serum zinc levels. Patients were followed up every 2 weeks. Histopathological examinations of the lesional tissue were done at baseline and after 6 weeks of therapy. Patients were given oral zinc daily and no other treatment during the 6 weeks course. RESULTS: All our patients were non-reactive to hepatitis-C. Of the ten patients only one patient (10%) showed low titer of serum zinc, another (10%) showed higher zinc level, while the rest of the patients had normal zinc level. Five of our patients had chronic renal failure, one had Grave's disease and the remaining had no associated systemic illness. Histopathology mostly showed hyperkeratosis, acanthosis, prominent granular layer, spongiosis and dermal infiltrate. After 6 weeks of follow up, all patients showed rapid and remarkable therapeutic response with zinc. CONCLUSIONS: We here report a series of patients, discernible because of their uniform clinical presentation of acral hypekeratotic plaques and in showing a noticeable response to zinc. Clinical, histopathological and laboratory investigations were done to rule out diseases of similar morphology including psoriasis, acral necrolytic erythema and lichen simplex chronicus. Authors understand that further studies with greater number cases and more detailed investigations are required to establish exact etio-pathogenesis and nomenclature of this distinct subset of patients.
format Online
Article
Text
id pubmed-4372904
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43729042015-03-26 Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis? Ghosh, Arghyaprasun Aggarwal, Ishad De, Abhishek Samanta, Ayan Chatterjee, Gobinda Bala, Sanchaita Biswas, Projna Chowdhary, Nidhi Indian J Dermatol Special Article BACKGROUND: We are reporting a series of interesting cases, which presented to us with psoriasiform lesions distributed over the acral regions of the body. The cases are unusual because they were resistant to conventional treatment modalities like topical corticosteroids, tacrolimus and oral methotrexate but showed significant improvement on oral zinc therapy. MATERIALS AND METHODS: Ten patients with characteristic clinical features of distinctive hyperkeratotic plaque in the acral areas, who were resistant to treatment by different modalities including potent topical steroids and oral methotrexate, were included for detailed investigations. A proper history was taken and relevant laboratory investigations were done which included blood count, urine, liver function, renal function, hepatitis-C virus serology and serum zinc levels. Patients were followed up every 2 weeks. Histopathological examinations of the lesional tissue were done at baseline and after 6 weeks of therapy. Patients were given oral zinc daily and no other treatment during the 6 weeks course. RESULTS: All our patients were non-reactive to hepatitis-C. Of the ten patients only one patient (10%) showed low titer of serum zinc, another (10%) showed higher zinc level, while the rest of the patients had normal zinc level. Five of our patients had chronic renal failure, one had Grave's disease and the remaining had no associated systemic illness. Histopathology mostly showed hyperkeratosis, acanthosis, prominent granular layer, spongiosis and dermal infiltrate. After 6 weeks of follow up, all patients showed rapid and remarkable therapeutic response with zinc. CONCLUSIONS: We here report a series of patients, discernible because of their uniform clinical presentation of acral hypekeratotic plaques and in showing a noticeable response to zinc. Clinical, histopathological and laboratory investigations were done to rule out diseases of similar morphology including psoriasis, acral necrolytic erythema and lichen simplex chronicus. Authors understand that further studies with greater number cases and more detailed investigations are required to establish exact etio-pathogenesis and nomenclature of this distinct subset of patients. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4372904/ /pubmed/25814700 http://dx.doi.org/10.4103/0019-5154.152507 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Article
Ghosh, Arghyaprasun
Aggarwal, Ishad
De, Abhishek
Samanta, Ayan
Chatterjee, Gobinda
Bala, Sanchaita
Biswas, Projna
Chowdhary, Nidhi
Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title_full Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title_fullStr Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title_full_unstemmed Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title_short Zinc-responsive acral hyperkeratotic dermatosis—A novel entity or a subset of some well-known dermatosis?
title_sort zinc-responsive acral hyperkeratotic dermatosis—a novel entity or a subset of some well-known dermatosis?
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372904/
https://www.ncbi.nlm.nih.gov/pubmed/25814700
http://dx.doi.org/10.4103/0019-5154.152507
work_keys_str_mv AT ghosharghyaprasun zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT aggarwalishad zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT deabhishek zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT samantaayan zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT chatterjeegobinda zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT balasanchaita zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT biswasprojna zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis
AT chowdharynidhi zincresponsiveacralhyperkeratoticdermatosisanovelentityorasubsetofsomewellknowndermatosis